SCSHP Annual Meeting 2022 (Virtual Conference)

SCSHP 2022 Annual Meeting

Thursday, March 3 - Friday March 4, 2022

To register and view the full meeting agenda, visit https://scshp.com/meetinginfo.php!

Location: Online Virtual Platform

For all continuing education session details, including speakers and learning objectives, please expand the individual sessions below!

Date: Mar 3, 2022 08:00 AM - Mar 4, 2022 05:30 PM

CE Hours

12.50

CE Units

1.250

Activity Type

Knowledge-Based and Application-Based

Target Audience(s)

Pharmacists
Pharmacy Technicians

Accreditation(s)

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Requirements for CE Credit

In order to claim credit and have CE credit submitted to the CPE Monitor, participants must complete the following steps within 60 days of the event. Completion of these steps within 30 days of the event will allow for any issues in transmission to NABP to be rectified by our office. The CPE Monitor will not accept credit that is submitted greater than 60 days after the event per NABP policy.

Check in upon arrival at the meeting
Complete the online program evaluations
Provide the correct month and day of birth and NABP e-Profile ID. Registration with a proper disclosure of your NABP E-Profile ID is a requirement for receiving Continuing Pharmacy Education. To register with or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.

Thu, Mar 03, 2022

Go with the Flozins: Expanded Role of SGLT2 Inhibitors for Chronic Kidney Disease

At the completion of this activity, the pharmacist will be able to:

Explain the mechanism of SGLT2i for CKD
Critically evaluate the published literature of renal outcomes regarding SGLT2i for CKD
Formulate a person-centered treatment plan with monitoring parameters for CKD

At the completion of this activity, the pharmacy technician will be able to:

Explain the mechanism of SGLT2i for CKD
Summarize a potential benefit and risk of SGLT2i on renal outcomes for CKD
Determine appropriate counseling points with a SGLT2i for a person with CKD

Speaker(s)/Author(s)

Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM
Clinical Professor and Director of Pharmacy Education, University of South Carolina College of Pharmacy

Activity Number

0062-9999-22-065-L01-P/T

Date: 03/03/22

Time: 09:30 AM - 10:30 AM

CE Hours

1.00

Professional Continuous Glucose Monitors in Primary Care

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Distinguish between professional and personal CGMs
Describe the characteristics of the different professional CGMs on the market
Define the role of a pharmacist in the implementation and interpretation of professional CGMs
Evaluate the effectiveness of professional CGMs in diabetes management

Speaker(s)/Author(s)

Aly York, PharmD PGY1 Outpatient Pharmacy Resident, Prisma Health Richland
Lawrence Bean, PharmD PGY1 Outpatient Pharmacy Resident, Prisma Health Richland

Activity Number

0062-9999-22-066-L01-P/T

Date: 03/03/22

Time: 11:00 AM - 12:00 PM

CE Hours

1.00

2022 Clinical Pharmacy Challenge: Part 1

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Activity Number

0062-9999-22-067-L01-P/T

Date: 03/03/22

Time: 12:00 PM - 01:00 PM

CE Hours

1.00

2022 Platform Presentations

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Discuss emerging research outcomes from throughout the state of South Carolina
Recognize novel ideas for research and quality initiative projects in your pharmacy practice areas
Review pivotal results from local investigations across the state of South Carolina

Speaker(s)/Author(s)

Carly Huggins, PharmD Candidate 2022 University of South Carolina College of Pharmacy
Gadison Quick, PharmD PGY2 Internal Medicine Pharmacy Resident, Prisma Health Richland Hospital
Rachel Robinson, PharmD Candidate Presbyterian College School of Pharmacy

Activity Number

0062-9999-22-068-L01-P/T

Date: 03/03/22

Time: 02:00 PM - 03:00 PM

CE Hours

1.00

2022 Clinical Pharmacy Challenge: Part 2

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Recall pharmacy trivia related to pharmacology, pharmacokinetics, pharmacodynamics, pharmacogenomics, clinical pharmacy history, biostatistics, and health outcomes
Summarize clinical knowledge in response to a case vignette using supporting laboratory, physical examination, and medical history information
Discuss numerous drug therapy and specialty areas through response to pharmacotherapy questions

Activity Number

0062-9999-22-069-L01-P/T

Date: 03/03/22

Time: 03:30 PM - 04:00 PM

CE Hours

0.50

Fri, Mar 04, 2022

The Pharmacologic Management of HFpEF: Is there a change of heart?

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Differentiate between the types of heart failure (HF)
Describe the pathophysiology of HF
Examine the historical pharmacologic management of Heart failure with preserved ejection fraction (HFpEF)
Analyze recent primary literature related to the management of HFpEF
Develop a treatment plan with monitoring when given a patient scenario with HFpEF

Speaker(s)/Author(s)

Katy Wolfe, PharmD PGY1 Pharmacy Resident, Spartanburg Medical Center
Sanyia Khan, PharmD CVICU Clinical Specialist, Spartanburg Medical Center

Activity Number

0062-9999-22-070-L01-P/T

Date: 03/04/22

Time: 08:00 AM - 09:00 AM

CE Hours

1.00

Hit Me With Your Best Shot: Cabotegravir/Rilpivirine Long-acting Injectable

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Summarize the efficacy and safety of cabotegravir/rilpivirine long-acting injectable for HIV treatment
Describe the workflow of implementing cabotegravir/rilpivirine long-acting injectable into real-world practice
Apply current recommendations regarding cabotegravir/rilpivirine long-acting injectable for the treatment of HIV

Speaker(s)/Author(s)

Morgan Pizzuti, PharmD PGY2 Infectious Diseases Pharmacy Resident, Prisma Health - Richland, University of South Carolina
Y. Vivian Tsai, PharmD Infectious Diseases Clinical Pharmacy Fellow, Prisma Health Richland - University of South Carolina

Activity Number

0062-9999-22-071-L02-P/T

Date: 03/04/22

Time: 09:00 AM - 10:00 AM

CE Hours

1.00

Don’t Sugarcoat It: Overview and Updates on Diabetic Ketoacidosis

At the completion of this activity, the pharmacist will be able to:

Describe the pathophysiology and clinical presentation of diabetic ketoacidosis (DKA)
Identify electrolyte disturbances often associated with DKA
Review treatment guidelines for DKA
Evaluate recent literature for selection of IV fluids in treatment of DKA
Define euglycemic DKA and the risks associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors

At the completion of this activity, the pharmacy technician will be able to:

Describe the presentation of diabetic ketoacidosis (DKA)
Identify electrolyte disturbances often associated with DKA
Recognize therapeutic options for DKA

Speaker(s)/Author(s)

Amanda Guffey, PharmD, BCCCP, BCPS
Clinical Pharmacist – Critical Care, Lexington Medical Center

Activity Number

0062-9999-22-072-L01-P/T

Date: 03/04/22

Time: 10:15 AM - 11:15 AM

CE Hours

1.00

Antiplatelet Optimization in Acute Coronary Syndromes

At the completion of this activity, the pharmacist will be able to:

Describe the role of antiplatelets in the pathophysiology of coronary artery disease
Assess patient-specific characteristics, including ischemic and bleeding risks, to evaluate selection of antiplatelet management
Examine guidelines and clinical trial recommendations for P2Y12 inhibitor selection, duration, and dose in acute coronary syndromes
Develop an individualized, patient-center approach regarding antiplatelet management in coronary artery disease

At the completion of this activity, the pharmacy technician will be able to:

Describe the role of antiplatelets in the pathophysiology of coronary artery disease
Recognize patient-specific characteristics that impact the selection of antiplatelet management
Discuss the role of shared decision making in the treatment of coronary artery disease

Speaker(s)/Author(s)

Ashley Costello, PharmD, BCPS
Clinical Pharmacist, Self Regional Healthcare

Activity Number

0062-9999-22-073-L01-P/T

Date: 03/04/22

Time: 11:15 AM - 12:15 PM

CE Hours

1.00

An Evidence-Based Approach to Double-Covering Pseudomonas (Or Not)

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Review the microbiology, pathogenicity, and common mechanisms of resistance of Pseudomonas aeruginosa
List the typical antibiotics utilized to treat Pseudomonas infections
Evaluate the guidelines and other literature surrounding the treatment of Pseudomonas infections

Speaker(s)/Author(s)

Michael K. Shaw, PharmD
PGY2 Infectious Diseases Pharmacy Resident, Prisma Health Richland

Activity Number

0062-9999-22-074-L01-P/T

Date: 03/04/22

Time: 12:15 PM - 12:45 PM

CE Hours

0.50

The Path of Most Resistance: Where New Antimicrobial Agents Fit Into Practice

At the completion of this activity, the pharmacist will be able to:

Describe mechanisms of action and mechanisms of resistance to new antimicrobial agents including eravacycline, imipenem/cilastatin/relebactam, and cefiderocol
Evaluate in vitro literature for these agents as well as clinical trials
Select an antimicrobial agent based on resistance patterns, type of infection, and strength of clinical evidence

At the completion of this activity, the pharmacy technician will be able to:

Recall the mechanisms of action and mechanisms of resistance to new antimicrobial agents
Recognize pharmacologic management strategies for resistant microbial infections

Speaker(s)/Author(s)

Kelli R. Keats, PharmD, MPA, BCCCP
Critical Care Pharmacist – Medical ICU, Augusta University Medical Center

Activity Number

0062-9999-22-075-L01-P/T

Date: 03/04/22

Time: 01:30 PM - 02:30 PM

CE Hours

1.00

Reverse, Reverse! Antithrombotic Reversal Overview

At the completion of this activity, the pharmacist and pharmacy technician will be able to:

Evaluate the difference between major and non-major bleeding
Summarize current pharmacological interventions for antithrombotic reversal
Demonstrate understanding of antithrombotic reversal agent mechanisms of action
Review literature regarding controversies related to antithrombotic reversal

Speaker(s)/Author(s)

Katrina Phelps, PharmD
PGY1 Pharmacy Resident, Bon Secours St. Francis Downtown

Activity Number

0062-9999-22-076-L01-P/T

Date: 03/04/22

Time: 02:30 PM - 03:30 PM

CE Hours

1.00

Let’s Put Our Heads Together: A Debate on Acute Ischemic Stroke Management

At the completion of this activity, the pharmacist will be able to:

Compare and contrast eligibility criteria for thrombolytic therapy in acute ischemic stroke patients on the basis of emerging literature
Interpret the role and supporting evidence behind tenecteplase as an alternative to traditional thrombolytic treatment of stroke
Describe endovascular treatments for ischemic stroke, indications for use, eligibility of patients, and the concomitant use of thrombolytics
Develop treatment recommendations incorporating appropriate diagnostic modalities for a patient presenting with stroke-like symptoms

At the completion of this activity, the pharmacy technician will be able to:

List common eligibility criteria for thrombolytic therapy in acute ischemic stroke
Describe the dosing and administration of tenecteplase for stroke treatment
Recognize non-pharmacologic treatments for ischemic stroke and the role for thrombolysis in patients undergoing endovascular therapies
Outline treatment recommendations for the management of acute ischemic stroke

Speaker(s)/Author(s)

Charles “Trey” Wingerson III, PharmD Assistant Professor, Presbyterian College School of Pharmacy
Jimmy L. Pruitt III, PharmD, BCPS Emergency Medicine Clinical Pharmacy Specialist

Activity Number

0062-9999-22-077-L01-P/T

Date: 03/04/22

Time: 04:00 PM - 05:30 PM

CE Hours

1.50